Clinical Trial Update: Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of IP2018 in patients with erectile dysfunction is in progress, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• IP2018

Snippet

Sponsor: Initiator Pharma | Conditions: Erectile Dysfunction | Phase 2 | Status: UNKNOWN